Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-005482
Filing Date
2019-08-14
Accepted
2019-08-14 08:00:24
Documents
10
Period of Report
2019-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_081419.htm 6-K 10870
2 EXHIBIT 99.1 exh_991.htm EX-99.1 286625
3 EXHIBIT 99.2 exh_992.htm EX-99.2 297123
4 EXHIBIT 99.3 exh_993.htm EX-99.3 10047
5 EXHIBIT 99.4 exh_994.htm EX-99.4 10045
6 GRAPHIC logo.jpg GRAPHIC 9757
7 GRAPHIC htg.jpg GRAPHIC 55816
8 GRAPHIC htg2.jpg GRAPHIC 48765
9 GRAPHIC trip3.jpg GRAPHIC 35862
10 GRAPHIC carepredev.jpg GRAPHIC 30441
  Complete submission text file 0001171843-19-005482.txt   865120
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 191022872
SIC: 2834 Pharmaceutical Preparations